A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population

Hamdi Mbarek1, Hidenori Ochi, Yuji Urabe

  • 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo.

Insights

Genetic factors in the HLA-DP and HLA-DQ regions significantly influence susceptibility to chronic hepatitis B (CHB) infection. Specific HLA-DQ variants were identified as independent risk or protective factors for developing CHB.

Area of Science:

  • Immunogenetics
  • Hepatology
  • Human Genetics

Background:

  • Hepatitis B virus (HBV) infection poses a global health threat, potentially leading to severe liver conditions like cirrhosis and cancer.
  • Identifying host genetic factors is crucial for understanding chronic hepatitis B (CHB) susceptibility.

Purpose of the Study:

  • To conduct a genome-wide association study (GWAS) to identify host genetic factors associated with CHB susceptibility in Japanese populations.
  • To further investigate the association of HLA-DP and HLA-DQ variants with CHB risk.

Main Methods:

  • Performed a second-stage GWAS using 519,474 single nucleotide polymorphism (SNP) arrays in 458 Japanese CHB cases and 2056 controls.
  • Analyzed significant loci in three independent Japanese cohorts (2209 CHB cases and 4440 controls).
  • Conducted haplotype analyses to identify specific HLA-DQ variants associated with CHB risk.

Main Results:

  • Identified strong associations at 16 loci with P-value < 5 × 10(-5) after adjusting for known HLA-DP variants.
  • Confirmed significant associations for two SNPs (rs2856718 and rs7453920) in the HLA-DQ locus (overall P-values < 4 × 10(-28)).
  • Discovered protective haplotypes (DQA1*0102-DQB1*0604, DQA1*0101-DQB1*0501) and risk haplotypes (DQA1*0102-DQB1*0303, DQA1*0301-DQB1*0601) for CHB.

Conclusions:

  • Variants within the antigen-binding regions of HLA-DP and HLA-DQ significantly contribute to the risk of persistent HBV infection.
  • HLA-DQ variants demonstrate an independent effect on CHB susceptibility, distinct from previously identified HLA-DP associations.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...